Recent advances in biomarker research, driven by biological therapies, have identified various CRS clusters with distinct inflammatory profiles, predominantly Th2 high IL-5 levels are associated with a nasal polyp phenotype and increased asthma prevalence47. The gene discussed is IL5; the disease is nasal cavity polyp.